NewEdge Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.13K | Buy |
396
+16
| +4% | +$248 | ﹤0.01% | 3356 |
|
|
2025
Q1 | $5.66K | Sell |
380
-25
| -6% | -$372 | ﹤0.01% | 3268 |
|
|
2024
Q4 | $5.37K | Buy |
405
+1
| +0.2% | +$13 | ﹤0.01% | 3222 |
|
|
2024
Q3 | $5.75K | Sell |
404
-12
| -3% | -$171 | ﹤0.01% | 3124 |
|
|
2024
Q2 | $5.39K | Sell |
416
-18
| -4% | -$233 | ﹤0.01% | 3075 |
|
|
2024
Q1 | $6.03K | Sell |
434
-92
| -17% | -$1.28K | ﹤0.01% | 3071 |
|
|
2023
Q4 | $7.51K | Sell |
526
-38,294
| -99% | -$546K | ﹤0.01% | 2973 |
|
|
2023
Q3 | $601K | Sell |
38,820
-334
| -0.9% | -$5.17K | 0.01% | 1086 |
|
|
2023
Q2 | $615K | Buy |
39,154
+38,794
| +10,776% | +$609K | 0.01% | 1082 |
|
|
2023
Q1 | $5.93K | Sell |
360
-5,092
| -93% | -$83.9K | ﹤0.01% | 2724 |
|
|
2022
Q4 | $79.4K | Buy |
+5,452
| New | +$79.4K | ﹤0.01% | 1530 |
|